| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Asthma | D001249 | 52 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Hypercholesterolemia | D006937 | 91 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Cerebral Hemorrhage | D002543 | 13 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Cerebrovascular Disorders | D002561 | 25 associated lipids |
| Polycythemia Vera | D011087 | 13 associated lipids |
| Hyperlipidemias | D006949 | 73 associated lipids |
| Blood Platelet Disorders | D001791 | 12 associated lipids |
| Albuminuria | D000419 | 18 associated lipids |
| Renal Artery Obstruction | D012078 | 8 associated lipids |
| Atrial Fibrillation | D001281 | 16 associated lipids |
| Atherosclerosis | D050197 | 85 associated lipids |
| Death, Sudden, Cardiac | D016757 | 12 associated lipids |
| Hypoalphalipoproteinemias | D052456 | 5 associated lipids |
11-dehydro-txb2
Cross Reference
Introduction
To understand associated biological information of 11-dehydro-txb2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 11-dehydro-txb2?
11-dehydro-txb2 is suspected in Risk factor, cardiovascular, Acute coronary syndrome, thrombocytosis, Chronic ischemic heart disease NOS, Diabetes Mellitus, Diabetes Mellitus, Non-Insulin-Dependent and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 11-dehydro-txb2
PubChem Associated disorders and diseases
What pathways are associated with 11-dehydro-txb2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 11-dehydro-txb2?
There are no associated biomedical information in the current reference collection.
What functions are associated with 11-dehydro-txb2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 11-dehydro-txb2?
There are no associated biomedical information in the current reference collection.
What genes are associated with 11-dehydro-txb2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 11-dehydro-txb2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 11-dehydro-txb2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Di Minno MN et al. | Increased platelet reactivity in Klinefelter men: something new to consider. | 2015 | Andrology | pmid:26216452 |
| pmid:26385032 | ||||
| Lüdicke F et al. | A Japanese cross-sectional multicentre study of biomarkers associated with cardiovascular disease in smokers and non-smokers. | 2015 | Biomarkers | pmid:26616146 |
| Santilli F et al. | Pentraxin 3 and Platelet Activation in Obese Patients After Gastric Banding. | 2016 | Circ. J. | pmid:26632534 |
| Liu TF et al. | [Correlation between the level of the urinary 11-dehydrothromboxane B2 and the clinical efficacy of aspirin in patients with type 2 diabetes and coronary artery disease]. | 2015 | Beijing Da Xue Xue Bao | pmid:26679651 |
| Kakouros N et al. | Risk Factors for Nonplatelet Thromboxane Generation After Coronary Artery Bypass Graft Surgery. | 2016 | J Am Heart Assoc | pmid:27068626 |
| pmid:27098431 | ||||
| pmid:27137142 | ||||
| pmid:27237049 | ||||
| pmid:27389698 | ||||
| pmid:27481134 | ||||
| Maga P et al. | 11-dehydro thromboxane B2 levels after percutaneous transluminal angioplasty in patients with peripheral arterial occlusive disease during a one year follow-up period. | 2016 | J. Physiol. Pharmacol. | pmid:27511998 |
| Ciabattoni G et al. | Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man. | 1989 | Biochim. Biophys. Acta | pmid:2752040 |
| Patrignani P et al. | Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey. | 1989 | Biochim. Biophys. Acta | pmid:2752041 |
| pmid:27609361 | ||||
| pmid:27693274 | ||||
| Lorenz R et al. | A new method using simple solid phase extraction for the rapid gas-chromatographic mass-spectrometric determination of 11-dehydro-thromboxane B2 in urine. | 1989 | Prostaglandins | pmid:2772221 |
| pmid:27769511 | ||||
| pmid:27784132 | ||||
| pmid:27815971 | ||||
| pmid:28005558 | ||||
| pmid:28139223 | ||||
| pmid:28911508 | ||||
| Lawson JA et al. | Long-lived enzymatic metabolites of thromboxane B2 in the human circulation. | 1986 | Anal. Biochem. | pmid:3087234 |
| Seyberth HW et al. | Excretion of primary prostanoids and their metabolites during acute volume expansion. | 1988 | Prostaglandins | pmid:3163156 |
| Alessandrini P et al. | Thromboxane biosynthesis and platelet function in type I diabetes mellitus. | 1988 | N. Engl. J. Med. | pmid:3292913 |
| Catella F et al. | 11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. | 1986 | Proc. Natl. Acad. Sci. U.S.A. | pmid:3461463 |
| Westlund P et al. | Circulating and urinary thromboxane B2 metabolites in the rabbit: 11-dehydro-thromboxane B2 as parameter of thromboxane production. | 1986 | Prostaglandins | pmid:3520685 |
| Fitzgerald DJ et al. | Platelet activation in unstable coronary disease. | 1986 | N. Engl. J. Med. | pmid:3531859 |
| Ciabattoni G et al. | Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine. | 1987 | Biochim. Biophys. Acta | pmid:3567215 |
| Fitzgerald DJ et al. | Increased thromboxane biosynthesis in normal pregnancy is mainly derived from platelets. | 1987 | Am. J. Obstet. Gynecol. | pmid:3618681 |
| Schweer H et al. | Tandem mass spectrometric determination of 11-dehydrothromboxane B2, an index metabolite of thromboxane B2 in plasma and urine. | 1987 | Anal. Biochem. | pmid:3674365 |
| Westlund P et al. | Identification of 11-dehydro-TXB2 as a suitable parameter for monitoring thromboxane production in the human. | 1986 | Prostaglandins | pmid:3755250 |
| Kumlin M and Granström E | Radioimmunoassay for 11-dehydro-TXB2: a method for monitoring thromboxane production in vivo. | 1986 | Prostaglandins | pmid:3823488 |
| Jörres A et al. | Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass. | 1994 | Artif Organs | pmid:7527629 |
| Cipollone F et al. | Effects of nabumetone on prostanoid biosynthesis in humans. | 1995 | Clin. Pharmacol. Ther. | pmid:7554708 |
| Ferretti A and Flanagan VP | Mass spectrometric evidence for the anomalous chemical behavior of 11-dehydrothromboxane B2. | 1995 | Chem. Phys. Lipids | pmid:7586090 |
| Milani M et al. | Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia. | 1995 | Am. J. Cardiol. | pmid:7604798 |
| Benowitz NL et al. | Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. | 1993 | J. Am. Coll. Cardiol. | pmid:7691912 |
| Schlit AF et al. | Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives. | 1995 | Contraception | pmid:7750285 |
| Kawamura M et al. | Evaluation of plasma 11-dehydro-thromboxane B2 as an indicator for thromboxane A2 synthesis in vivo in laboratory animals. | 1995 | Thromb. Res. | pmid:7778061 |
| Chiabrando C et al. | Urinary excretion of 2,3-dinor-thromboxane B1, a major metabolite of thromboxane B2 in the rat. | 1994 | Prostaglandins | pmid:7938613 |
| Wallén NH et al. | Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris. | 1994 | Br J Clin Pharmacol | pmid:7946939 |
| Pape HC et al. | Does the reamer type influence the degree of lung dysfunction after femoral nailing following severe trauma? An animal study. | 1994 | J Orthop Trauma | pmid:7965291 |
| Kitano A et al. | Increased 11-dehydrothromboxane B2 in migraine: platelet hyperfunction in patients with migraine during headache-free period. | 1994 | Headache | pmid:8002323 |
| Larsson PT et al. | Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. | 1994 | Circulation | pmid:8181117 |
| Djurup R et al. | Rapid, direct enzyme immunoassay of 11-keto-thromboxane B2 in urine, validated by immunoaffinity/gas chromatography-mass spectrometry. | 1993 | Clin. Chem. | pmid:8252718 |
| Smith SR et al. | Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity. | 1993 | Transplantation | pmid:8279014 |
| van Kooten F et al. | Evidence for episodic platelet activation in acute ischemic stroke. | 1994 | Stroke | pmid:8303731 |
| Foegh ML et al. | Urinary thromboxane A2 metabolites in patients presenting in the emergency room with acute chest pain. | 1994 | J. Intern. Med. | pmid:8308478 |